HEN STEWART

Director at Altus Pharmaceuticals Inc. · on record since Jan 25, 2006
Director at NEUROGEN CORP · on record since Mar 16, 2006
10% owner at Altus Pharmaceuticals Inc. · on record since Feb 2, 2006
Director at ALLOS THERAPEUTICS INC · on record since May 12, 2006
See Remarks at NEUROGEN CORP · on record since Dec 24, 2009

Insider trading activity of HEN STEWART

Transactions on record: 52; since Apr 21, 2004

Open-market buys: 1; $19.7M

Open-market sells: 0

Companies traded: 3; last filing Dec 24, 2009

Figures computed from official regulatory filings — .

Companies where HEN STEWART has traded

NEUROGEN CORP36 tx · Dec 24, 2009
ALLOS THERAPEUTICS INC8 tx · $20.2M · Jun 23, 2009
Altus Pharmaceuticals Inc.8 tx · $7M · Jun 13, 2008

Track record of HEN STEWART

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of HEN STEWART

Co-insiders of HEN STEWART

LEFF JONATHAN SALLOS THERAPEUTICS INC +2
WARBURG PINCUS & COALLOS THERAPEUTICS INC +2
WARBURG PINCUS LLCALLOS THERAPEUTICS INC +2
Warburg Pincus Partners LLCALLOS THERAPEUTICS INC +2
WARBURG PINCUS PRIVATE EQUITY VIII L PALLOS THERAPEUTICS INC +2
Baker Biotech Capital (GP), LLCALLOS THERAPEUTICS INC +1
Baker Biotech Capital III (GP), LLCALLOS THERAPEUTICS INC +1
Baker Bros. Capital (GP), LLCALLOS THERAPEUTICS INC +1
BAKER FELIXALLOS THERAPEUTICS INC +1
BAKER JULIANALLOS THERAPEUTICS INC +1
Baker / Tisch Capital (GP), LLCALLOS THERAPEUTICS INC +1
KAYE CHARLES RALLOS THERAPEUTICS INC +1
LANDY JOSEPHALLOS THERAPEUTICS INC +1

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NEUROGEN CORPListing unverified	Dec 24, 2009	OtherD (derivative)	-90,042	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Dec 24, 2009	Other	-13,571,411	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Dec 17, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Sep 16, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Jun 23, 2009	AwardD (derivative)	20,000	7.33	$146.6K	Unusual size	SEC
NEUROGEN CORPListing unverified	Jun 16, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Mar 17, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Dec 17, 2008	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Sep 29, 2008	AwardD (derivative)	1,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Sep 25, 2008	OtherD (derivative)	-192,307	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Sep 25, 2008	Other	4,999,982	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Sep 17, 2008	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Jul 28, 2008	OtherD (derivative)	-192,307	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Jul 28, 2008	Other	4,999,982	—	n/a (No price was disclosed in the filing)		SEC
ALLOS THERAPEUTICS INCListing unverified	Jun 26, 2008	AwardD (derivative)	20,000	6.30	$126K	Unusual size	SEC
NEUROGEN CORPListing unverified	Jun 17, 2008	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Altus Pharmaceuticals Inc.Listing unverified	Jun 13, 2008	AwardD (derivative)	10,903	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	May 30, 2008	Buy	3,500,000	5.64	$19.7M	conv 47Cluster	SEC
NEUROGEN CORPListing unverified	Apr 14, 2008	BuyD (derivative)	192,307	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
NEUROGEN CORPListing unverified	Apr 14, 2008	BuyD (derivative)	192,307	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
NEUROGEN CORPListing unverified	Mar 18, 2008	AwardD (derivative)	2,500	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Dec 17, 2007	AwardD (derivative)	2,500	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Sep 17, 2007	AwardD (derivative)	2,500	—	n/a (No price was disclosed in the filing)		SEC
Altus Pharmaceuticals Inc.Listing unverified	Jun 28, 2007	AwardD (derivative)	10,903	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Jun 21, 2007	AwardD (derivative)	20,000	5.63	$112.6K	Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NEUROGEN CORPListing unverified	Dec 24, 2009	OtherD (derivative)	-90,042	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Dec 24, 2009	Other	-13,571,411	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Dec 17, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Sep 16, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Jun 23, 2009	AwardD (derivative)	20,000	7.33	$146.6K	Unusual size	SEC
NEUROGEN CORPListing unverified	Jun 16, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Mar 17, 2009	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Dec 17, 2008	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Sep 29, 2008	AwardD (derivative)	1,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Sep 25, 2008	OtherD (derivative)	-192,307	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Sep 25, 2008	Other	4,999,982	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Sep 17, 2008	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROGEN CORPListing unverified	Jul 28, 2008	OtherD (derivative)	-192,307	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Jul 28, 2008	Other	4,999,982	—	n/a (No price was disclosed in the filing)		SEC
ALLOS THERAPEUTICS INCListing unverified	Jun 26, 2008	AwardD (derivative)	20,000	6.30	$126K	Unusual size	SEC
NEUROGEN CORPListing unverified	Jun 17, 2008	AwardD (derivative)	2,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Altus Pharmaceuticals Inc.Listing unverified	Jun 13, 2008	AwardD (derivative)	10,903	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	May 30, 2008	Buy	3,500,000	5.64	$19.7M	conv 47Cluster	SEC
NEUROGEN CORPListing unverified	Apr 14, 2008	BuyD (derivative)	192,307	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
NEUROGEN CORPListing unverified	Apr 14, 2008	BuyD (derivative)	192,307	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
NEUROGEN CORPListing unverified	Mar 18, 2008	AwardD (derivative)	2,500	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Dec 17, 2007	AwardD (derivative)	2,500	—	n/a (No price was disclosed in the filing)		SEC
NEUROGEN CORPListing unverified	Sep 17, 2007	AwardD (derivative)	2,500	—	n/a (No price was disclosed in the filing)		SEC
Altus Pharmaceuticals Inc.Listing unverified	Jun 28, 2007	AwardD (derivative)	10,903	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALLOS THERAPEUTICS INCListing unverified	Jun 21, 2007	AwardD (derivative)	20,000	5.63	$112.6K	Unusual size	SEC